Nature-Inspired Nanoparticles as Paclitaxel Targeted Carrier for the Treatment of HER2-Positive Breast Cancer

SIMPLE SUMMARY: Great advances have been made in the treatment of an aggressive subtype of breast cancer, known as HER2-positive subtype. However, the antitumor therapy most widely employed in the clinical fight against it has severe side effects, and the apparition of treatment resistances is frequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieto, Celia, Vega, Milena A., Martín del Valle, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196773/
https://www.ncbi.nlm.nih.gov/pubmed/34064007
http://dx.doi.org/10.3390/cancers13112526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196773/
https://www.ncbi.nlm.nih.gov/pubmed/34064007
http://dx.doi.org/10.3390/cancers13112526

Ejemplares similares